NEOP is not necessarily a bad company; however, the stock became overvalued from heavy pumping on some iHub boards (and other venues) in much the same way that FCSC did prior to FDA approval of laViv. I would have shorted both names if I had been able to get a borrow.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.